Supporting Infection Prevention and Control and Optimizing the Use of Antimicrobial Medicines
Funded by the US Agency for International Development and led by Management Sciences for Health (MSH), the goal of the five-year MTaPS program (2018–2023) is to help low and middle-income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines and pharmaceutical services.
MTaPS will support the Global Health Security Agenda (GHSA), whose purpose is to help build countries’ capacity to protect themselves from infectious disease threats and to raise global health security as a national and global priority. The GHSA comprises 11 action packages, including one to combat antimicrobial resistance (AMR). MTaPS’ work will help GHSA target countries advance USAID’s AMR action package-related objectives.